	Crizotinib or vebreltinib response and resistance in advanced non-small cell lung cancer with MET exon 14 skipping. Discov Oncol Yang J, Weng CD, Wang HM, Su JW, Tan QQ, Lin XC, Fang MM, Mao ZJ, Chen HJ, Li H, Lin G, Wu YL, Guo Y, Yang JJ. PMID: 42201505 [PubMed - as supplied by publisher]
	Mixed-Method Formative Evaluation and Cultural Adaptation of Digital Health Communication Content and Delivery Promoting Lung Cancer Screening Shared Decision-Making. Cancer Control King AJ, Li I, Morales JP, Banks A, Wight E, Kaphingst KA, Lam CY, Taber PA, Borsato EP, Schlechter CR, Del Fiol G, Kawamoto K, Wetter DW. PMID: 42201308 [PubMed - indexed for MEDLINE]
	Beyond the Scan: Adapting Multimodal Lung Cancer Screening for Central and Eastern Europe-Overcoming Systemic Barriers and Epidemiological Confounders. Med Sci (Basel) Anghel R, Folea AR, Moga VL, Pavel C, Troncot, Celea M, Dumitru CO, , Bîlteanu L. PMID: 42201051 [PubMed - indexed for MEDLINE]
	Impact of Variant Allele Frequency (VAF) Levels on Clinical Efficacy of Osimertinib in Patients with Metastatic NSCLC. Med Sci (Basel) Agbarya A, Mhameed K, Soklakova A, Nasrallah H, Abu Amna M, El-Saied S, Sheikh-Ahmad M, Shalata W. PMID: 42201025 [PubMed - indexed for MEDLINE]
	Sputum Liquid Biopsy for Lung Cancer Screening, Diagnosis, Subtyping, Surveillance, Response Prediction, and Prognostication: A Scoping Review. Med Sci (Basel) Rehman A, Awais M, Baloch HNUA, Leghari MO, Ahmad A, Javed H. PMID: 42201023 [PubMed - indexed for MEDLINE]
	Comparison of Post-Resistance Treatment Outcomes in EGFR-Mutated NSCLC Patients Following Third-Generation EGFR-TKI Therapy: A Retrospective Cohort Study. Technol Cancer Res Treat Li X, Ding K, Liu D, Song R, Peng Z, Xu Y, Lu Y. PMID: 42200358 [PubMed - indexed for MEDLINE]
	Prospective evaluation and clinical outcomes of adaptive radiotherapy for locally advanced non-small cell lung cancer (LA-NSCLC). Acta Oncol Carlsen IH, Dyvik VR, Johannessen TB, Fjellanger K, Sandvik IM, Hjørnevik JV, Sulen TH, Nybø T, Hundvin JA, Pilskog SMC, Fløtten Ø, Haakensen VD, Hysing LB. PMID: 42200217 [PubMed - indexed for MEDLINE]
	A spatial correlation-guided deep fusion framework for multimodal lung cancer classification using CT imaging. Front Med (Lausanne) Alharbi H. PMID: 42200072 [PubMed]
	Evaluation of dosimetric consistency between pre- and postoperative CT-guided noncoplanar template-assisted Â¹Â²âµI seed implantation in recurrent and metastatic thoracic tumors: a retrospective study. PeerJ Qiu L, Li Y, Wu R, Chen Y, Zhang Z, Zhan W, Zhang Y, Li Q, Bi A, Luo L, Chen W, Yan Z. PMID: 42199831 [PubMed - indexed for MEDLINE]
	The impact of comorbid type 2 diabetes on survival outcomes in patients with solid tumors treated with immune checkpoint inhibitors: a meta-analysis focusing on lung cancer. Front Endocrinol (Lausanne) Fan L, Xu W, Zhang Q, Li J, Bai W. PMID: 42199799 [PubMed - indexed for MEDLINE]
	Bronchial Arterial Chemoembolization with versus without Anlotinib in Elderly Patients with Advanced Non-Small Cell Lung Cancer: A Retrospective Case-Control Study. Clin Interv Aging Lai L, Si T, Yao H, Gong S, Duan X, Jin ZC, Zhang D, Ji J, Tu J. PMID: 42199484 [PubMed - indexed for MEDLINE]
	Negative regulators antagonizing antitumor innate immune pathways in lung cancer immune evasion. Front Immunol Yang F, Liu R, Liu L, Zhang A, Li B. PMID: 42199421 [PubMed - indexed for MEDLINE]
	Systemic toxicity and immunotoxicity studies of glucose oxidase-loaded extracellular vesicles derived from lung cancer cells. Front Immunol Grudzinski IP, Bamburowicz-Klimkowska M, Sochanowicz B, Brzoska K, Prochorec-Sobieszek M, Cabaj M, Targonska A, Stawarska A, Kruszewski M. PMID: 42199412 [PubMed - indexed for MEDLINE]
	Efficacy of PD-1/PD-L1 plus CTLA-4 inhibitors in advanced/metastatic NSCLC: a meta-analysis based on RCTs. Front Immunol Dai T, Chen Y, Dai X, Chen Y, Pan X, Chen J, Liu X. PMID: 42199400 [PubMed - indexed for MEDLINE]
	Correction: Irshad et al. A Novel IoT-Enabled Healthcare Monitoring Framework and Improved Grey Wolf Optimization Algorithm-Based Deep Convolution Neural Network Model for Early Diagnosis of Lung Cancer. Sensors 2023, 23, 2932. Sensors (Basel) Irshad RR, Hussain S, Sohail SS, Zamani AS, Madsen DØ, Alattab AA, Ahmed AAA, Norain KAA, Alsaiari OAS. PMID: 42198086 [PubMed - in process]
	See and Strike: A Dual-Force Paradigm for Real-Time Lung Cancer Diagnosis and Non-Thermal Ablation. Diagnostics (Basel) Khosa J, Cho RJ. PMID: 42196919 [PubMed]
	A Comparative Study of Rapid Fresh Pathology Imaging and Standard FFPE H&E Histopathology: A High Concordance in the Evaluation of Lung and Breast Cancer. Diagnostics (Basel) Hsieh MS, Tseng YC, Huang CY, Wang H, Lee YH, Lien HC, Huang HY, Chang K, Wang HC, Wang KC, Wang MY, Liao YH, Sun CK, Chen JS. PMID: 42196869 [PubMed]
	Machine Learning-Derived Risk Groups and Clinical Implementation of Survival Prediction in Lung Cancer: Evidence from a Kazakh National Cohort. Diagnostics (Basel) Avizova Z, Myssayev AO, Iztleuov YM. PMID: 42196845 [PubMed]
	East-West Disparities in Lung Cancer Screening: Subsolid Nodule Prevalence, Interval Growth, and Decision-Making Analysis. Diagnostics (Basel) Hung YC, Wu YJ, Wu FZ. PMID: 42196808 [PubMed]
	Effects of Inhaled Corticosteroids and Long-Acting Î²2-Agonists on Efferocytosis and Inflammatory Cell Survival: An In Vitro Study Relevant to COPD and Lung Cancer. Int J Mol Sci Redwan B, Biancosino C, Fischer S, Janciauskiene S, Golpon H. PMID: 42196603 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 159046

Page 1 of 7953



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy